Studies have shown that drug‐induced autophagy can significantly enhance the sensitivity of NSCLC to EGFR‐TKI,5 whether the induction of autophagy could enhance the sensitivity of BC cells to osimertinib has not been reported. The gene discussed is EGFR; the disease is breast cancer.